Log in
Enquire now
‌

US Patent 11219674 Therapeutic cancer vaccine

Patent 11219674 was granted and assigned to Cadila Pharmaceuticals on January, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Currently, there are no issues on this topic.

Find more entities like US Patent 11219674 Therapeutic cancer vaccine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.